Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik J M van Bommel

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Kidney International|March 24, 2020
The authors replyErik J M van Bommel, Daniël H van Raalte
The Lancet. Diabetes & Endocrinology|September 25, 2016
Renoprotection in LEADER and EMPA-REG OUTCOMEMarcel H A Muskiet, Lennart Tonneijck, Erik J M van Bommel, et al.
The Lancet. Diabetes & Endocrinology|November 23, 2015
Understanding EMPA-REG OUTCOMEMarcel H A Muskiet, Daniël H van Raalte, Erik J M van Bommel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 4, 2017
SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical OutcomeErik J M van Bommel, Marcel H A Muskiet, Lennart Tonneijck, et al.
Bone|May 6, 2018
The osteoblast: Linking glucocorticoid-induced osteoporosis and hyperglycaemia? A post-hoc analysis of a randomised clinical trialErik J M van Bommel, Renate T de Jongh, Myrte Brands, et al.
Kidney International Reports|November 9, 2020
Glucosuria Interferes With Measurement of Effective Renal Plasma Flow Using <i>para</i>-Aminohippuric Acid, With a Focus on SGLT2 InhibitorsRosalie A Scholtes, Isabel T N Nguyen, Erik J M van Bommel, et al.
Kidney International Reports|April 18, 2023
Acute Effects of Insulin Infusion on Kidney Hemodynamic Function in People With Type 2 Diabetes and Normal Kidney FunctionMichaël J B van Baar, Erik J M van Bommel, Daan J Touw, et al.
Journal of Diabetes and Its Complications|February 28, 2022
Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivityMichaël J B van Baar, Erik J M van Bommel, Mark M Smits, et al.
Kidney International|March 24, 2020
Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney functionErik J M van Bommel, Yuliya Lytvyn, Bruce A Perkins, et al.
Diabetes Care|October 31, 2019
Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal FunctionErik J M van Bommel, Danique Ruiter, Marcel H A Muskiet, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Kidney International|March 24, 2020
The authors replyErik J M van Bommel, Daniël H van Raalte
The Lancet. Diabetes & Endocrinology|September 25, 2016
Renoprotection in LEADER and EMPA-REG OUTCOMEMarcel H A Muskiet, Lennart Tonneijck, Erik J M van Bommel, et al.
The Lancet. Diabetes & Endocrinology|November 23, 2015
Understanding EMPA-REG OUTCOMEMarcel H A Muskiet, Daniël H van Raalte, Erik J M van Bommel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 4, 2017
SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical OutcomeErik J M van Bommel, Marcel H A Muskiet, Lennart Tonneijck, et al.
Bone|May 6, 2018
The osteoblast: Linking glucocorticoid-induced osteoporosis and hyperglycaemia? A post-hoc analysis of a randomised clinical trialErik J M van Bommel, Renate T de Jongh, Myrte Brands, et al.
Kidney International Reports|November 9, 2020
Glucosuria Interferes With Measurement of Effective Renal Plasma Flow Using <i>para</i>-Aminohippuric Acid, With a Focus on SGLT2 InhibitorsRosalie A Scholtes, Isabel T N Nguyen, Erik J M van Bommel, et al.
Kidney International Reports|April 18, 2023
Acute Effects of Insulin Infusion on Kidney Hemodynamic Function in People With Type 2 Diabetes and Normal Kidney FunctionMichaël J B van Baar, Erik J M van Bommel, Daan J Touw, et al.
Journal of Diabetes and Its Complications|February 28, 2022
Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivityMichaël J B van Baar, Erik J M van Bommel, Mark M Smits, et al.
Kidney International|March 24, 2020
Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney functionErik J M van Bommel, Yuliya Lytvyn, Bruce A Perkins, et al.
Diabetes Care|October 31, 2019
Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal FunctionErik J M van Bommel, Danique Ruiter, Marcel H A Muskiet, et al.
Pageof 2